PRADAXA (Rebel Distributors Corp)


Welcome to the PulseAid listing for the PRADAXA drug offered from Rebel Distributors Corp. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Rebel Distributors Corp
NON-PROPRIETARY NAME: dabigatran etexilate mesylate
SUBSTANCE NAME: DABIGATRAN ETEXILATE MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-10-26
END MARKETING DATE: 0000-00-00


PRADAXA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPRADAXA from Rebel Distributors Corp
LABELER NAME: Rebel Distributors Corp
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/1)
START MARKETING DATE: 2010-10-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 21695-899_5db7f199-8752-4d24-85f7-e34ca8f4d02e
PRODUCT NDC: 21695-899
APPLICATION NUMBER: NDA022512

Other DABIGATRAN ETEXILATE MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Boehringer Ingelheim Pharmaceuticals Inc.Pradaxa
Rebel Distributors CorpPRADAXA